Géraldine Teppaz

Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance

Vanessa Gauttier, Sabrina Pengam, Justine Durand et al. · Journal of Clinical Investigation · 2020 · 89 citations · Full text

Immunology, Immune Regulation, Immunotherapeutics +16

Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution

Charlène Trilleaud, Vanessa Gauttier, Kévin Biteau et al. · Science Advances · 2021 · 70 citations · Full text

Tumor targeting of the IL‐15 superagonist RLI by an anti‐GD2 antibody strongly enhances its antitumor potency

Marie Vincent, Anne Bessard, Denis Cochonneau et al. · International Journal of Cancer · 2013 · 64 citations · Full text

Tumor Environment, Il‐15 Superagonist Rli, Fusion Protein Rli +21

IL-15 <i>Trans</i>-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists

Mélanie Desbois, Pauline Le Vu, Clélia Coutzac et al. · The Journal of Immunology · 2016 · 58 citations

Enhances Antitumor Activity, Immunology, Immune Regulation +21

Toward Efficient Drug Screening by Homogeneous Assays Based on the Development of New Fluorescent Vasopressin and Oxytocin Receptor Ligands

Laura Albizu, Géraldine Teppaz, René Seyer et al. · Journal of Medicinal Chemistry · 2007 · 54 citations · Full text

Drug Target, Peptide Science, Molecular Pharmacology +23